Whitehawk Therapeutics Stock Alpha and Beta Analysis

WHWK Stock   2.72  0.05  1.87%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Whitehawk Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Whitehawk Therapeutics over a specified time horizon. Remember, high Whitehawk Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Whitehawk Therapeutics' market risk premium analysis include:
Beta
1.23
Alpha
0.58
Risk
6.53
Sharpe Ratio
0.1
Expected Return
0.66
Please note that although Whitehawk Therapeutics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Whitehawk Therapeutics did 0.58  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Whitehawk Therapeutics stock's relative risk over its benchmark. Whitehawk Therapeutics has a beta of 1.23  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Whitehawk Therapeutics will likely underperform. At this time, Whitehawk Therapeutics' Tangible Book Value Per Share is quite stable compared to the past year. Price Book Value Ratio is expected to rise to 1.54 this year, although Enterprise Value Multiple will most likely fall to (0.84).

Enterprise Value

(7.03 Million)

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Whitehawk Therapeutics Backtesting, Whitehawk Therapeutics Valuation, Whitehawk Therapeutics Correlation, Whitehawk Therapeutics Hype Analysis, Whitehawk Therapeutics Volatility, Whitehawk Therapeutics History and analyze Whitehawk Therapeutics Performance.
For more information on how to buy Whitehawk Stock please use our How to buy in Whitehawk Stock guide.

Whitehawk Therapeutics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Whitehawk Therapeutics market risk premium is the additional return an investor will receive from holding Whitehawk Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Whitehawk Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Whitehawk Therapeutics' performance over market.
α0.58   β1.23

Whitehawk Therapeutics expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Whitehawk Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Whitehawk Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Whitehawk Therapeutics Market Price Analysis

Market price analysis indicators help investors to evaluate how Whitehawk Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Whitehawk Therapeutics shares will generate the highest return on investment. By understating and applying Whitehawk Therapeutics stock market price indicators, traders can identify Whitehawk Therapeutics position entry and exit signals to maximize returns.

Whitehawk Therapeutics Return and Market Media

The median price of Whitehawk Therapeutics for the period between Fri, Oct 10, 2025 and Thu, Jan 8, 2026 is 2.3 with a coefficient of variation of 8.47. The daily time series for the period is distributed with a sample standard deviation of 0.2, arithmetic mean of 2.32, and mean deviation of 0.17. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Whitehawk Therapeutics Stock Is Trading Higher Thursday Whats Going On
10/16/2025
2
Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
11/06/2025
3
Whitehawk Therapeutics Inc. stock trend outlook and recovery path - Analyst Downgrade Community Consensus Stock Picks - newser.com
11/13/2025
4
Whitehawk Therapeutics stock holds steady as Jefferies maintains rating By Investing.com - Investing.com Nigeria
11/20/2025
5
Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer
12/01/2025
6
How Whitehawk Therapeutics Inc. stock performs in stagflation - July 2025 Retail Safe Capital Investment Plans - Newser
12/04/2025
7
Can Whitehawk Therapeutics Inc. stock weather global recession - 2025 Valuation Update Long-Term Growth Portfolio Plans -
12/18/2025
8
Published on 2026-01-07 232008 - ulpravda.ru
01/07/2026

About Whitehawk Therapeutics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Whitehawk or other stocks. Alpha measures the amount that position in Whitehawk Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2025 2026 (projected)
Dividend Yield0.01850.0165
Price To Sales Ratio3.783.59
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Whitehawk Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Whitehawk Therapeutics' short interest history, or implied volatility extrapolated from Whitehawk Therapeutics options trading.

Build Portfolio with Whitehawk Therapeutics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Whitehawk Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Whitehawk Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Whitehawk Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Whitehawk Therapeutics Stock:
Whitehawk Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Whitehawk Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Whitehawk Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...